Dexdor - direct healthcare professional communication (DHPC)

Dexmedetomidine hydrochloride

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Dexmedetomidine: Increased risk of mortality in intensive care unit (ICU) patients ≤65 years

Dissemination date: 16/06/2022

Key facts

• Medicine name:
  Dexdor
• Active substance:
  Dexmedetomidine hydrochloride
• Therapeutic area (MeSH):
  Conscious Sedation
• Procedure number:
  EMEA/H/C/002268/II/0035
• Regulatory outcome:
  Maintenance
• DHPC type:
  Safety signal
• Human ATC codes:
  N05CM18
• Dissemination date:
  16/06/2022